Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2009-08-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SENSIMED Triggerfish Safety and Tolerability
NCT01319617
Central Corneal Thickness With SENSIMED Triggerfish
NCT01210963
Use of an Ocular Telemetry Sensor in Diamox Treated Patients
NCT01028664
Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor
NCT01390779
SENSIMED Triggerfish in Closed Eyes
NCT01938287
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy subjects
SENSIMED Triggerfish
Ocular Telemetry Sensor for IOP monitoring
Glaucoma patients
SENSIMED Triggerfish
Ocular Telemetry Sensor for IOP monitoring
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SENSIMED Triggerfish
Ocular Telemetry Sensor for IOP monitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is 18-80 years old
* Healthy subject or glaucoma patient
* Patient has consented to be in the trial and signed informed consent is available before any study related procedures are carried out
* Cylinder refraction of no more than +/- 2 diopters in the study eye
* Visual acuity of 20/80 or better in the study eye
* Ability of subject to understand the character and individual consequences of the study
* For women with childbearing potential, adequate contraception
Exclusion Criteria
* Subjects with contraindications for wearing contact lenses
* History of refractive surgery
* History of intraocular surgery in the last three months
* Severe dry eye syndrome
* Keratoconus or other corneal abnormalities
* Conjunctival or intraocular inflammation
* Pregnancy and lactation
* Simultaneous participation in other clinical trials
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sensimed AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Norbert Pfeiffer, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Universitätsmedizin Mainz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.